文献速递先天性心脏病外科心外重症与机械循环支持

儿童心脏移植后血管麻痹:连续流心室辅助装置支持的影响

Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-02-06

单中心回顾性队列研究纳入44例接受原位心脏移植的3岁及以上患儿,其中21例术前使用连续流心室辅助装置。血管麻痹未显著增加不良结局,但急性肾损伤和住院时间有升高趋势。

要点

  • 儿童心脏移植前使用连续流心室辅助装置与术后血管麻痹风险增加相关。
  • 研究提出适用于儿童的血管麻痹临床定义,基于血管收缩药使用、舒张压降低、收缩功能保留及无感染等。
  • 血管麻痹未显著关联不良结局,但需警惕急性肾损伤和住院时间延长趋势。

核心结论

  • 儿童接受连续流心室辅助装置支持后,原位心脏移植术后发生血管麻痹的风险增加。
  • 血管麻痹与不良结局无显著关联,但急性肾损伤和住院时间有升高趋势。

研究设计与样本

  • 单中心回顾性队列研究,设置于三级儿童医院心血管重症监护室。
  • 纳入2014年4月1日至2017年7月31日在斯坦福大学接受原位心脏移植的3岁及以上患者,共44例。

主要发现

  • 44例患者中21例术前使用连续流心室辅助装置,14例(32%)术后发生血管麻痹。
  • 单因素分析中其他变量均不能预测血管麻痹。

关键数值与推荐

  • 血管麻痹定义:使用血管收缩药物、舒张压降低、收缩功能保留、无感染或右心房压/中心静脉压<5 mm Hg。

临床怎么用

  • 对接受连续流心室辅助装置支持的儿童心脏移植患者,应预判血管麻痹风险并及时干预,以减少血流动力学不稳定。

局限性

  • 单中心回顾性研究,样本量有限,血管麻痹定义为新提出且需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the association between continuous flow ventricular assist devices and the incidence of vasoplegia following orthotopic heart transplant in children. Moreover, to propose a novel clinical definition of vasoplegia for use in pediatric populations. METHODS: This is a single-center, retrospective cohort study set in the cardiovascular intensive care unit of a tertiary children's hospital. All patients aged 3 years and older who underwent orthotopic heart transplant at Stanford University between April 1, 2014, and July 31, 2017, were included. Vasoplegia was defined by the use of vasoconstrictive medication, diastolic hypotension, preserved systolic heart function, and absence of infection or right atrial pressure or central venous pressure <5 mm Hg. RESULTS: Of 44 eligible patients, 21 were supported using a continuous flow ventricular assist device. Following heart transplant, 14 patients (32%) developed vasoplegia by the study definition. Development of vasoplegia was associated with pretransplant use of a continuous flow ventricular assist device (52% vs 13%) with a relative risk of 4.02 (95% confidence interval, 1.30-12.45; P = .009). No other variables were predictive of vasoplegia in univariable analysis. Presence of vasoplegia was not associated with adverse outcomes, although there were trends towards higher incidence of acute kidney injury and increased length of hospital stays. CONCLUSIONS: Children receiving continuous flow ventricular assist device support are at increased risk for vasoplegia following orthotopic heart transplant, using a novel definition of vasoplegia. Anticipation of this complication will allow for prompt intervention, thereby minimizing hemodynamic instability and impact on patient outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sacks LD, Hollander SA, Zhang Y, et al. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device. J Thorac Cardiovasc Surg. 2019. PMID: 30929985. doi:10.1016/j.jtcvs.2019.01.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。